1st Edition
The Thriving Biopharma Business How to Unlock Value and Drive Success in Biotech and Pharma
Preface
Acknowledgments
Chapter 1 Setting the Stage for Biopharma Innovation
Chapter 2 The Basic Valuation Toolkit
Chapter 3 The Rigors and Importance of Intellectual Property
Chapter 4 Strategy for Biopharma Companies
Chapter 5 Company Financing
Chapter 6 Pitching Your Company
Chapter 7 Understanding the Art of the Deal in Biopharma
Chapter 8 Contractual Considerations for Biopharma Deals
Chapter 9 Essential Regulatory Notions
Index
Biography
Alain Eudaric brings over 30 years of global expertise in biopharma, life sciences, and consulting, specializing in strategy, M&A, alliances, and innovation-led growth. He has held leadership roles at Kearney, Thermo Fisher Scientific, and Parexel International, driving transformative programs and business success. As President of Idea Pathways, Alain focuses on driving operational excellence and fostering innovative growth strategies for the biopharma industry. He is an alum from Harvard Medical School, Johns Hopkins University, MIT, Purdue University, and Ecole Centrale de Lille with advanced degrees in Biotech, Business, Science, and Engineering.
Jean-Noël Pellegrin has over 15 years of expertise in M&A and business development, with a proven track record of contributing to several hundred successful transactions. He began his career at EY before most recently joining Sanofi, where he has spent the last 20 years in France and the United States. His 30 years of combined experience across global public company financa, audit, accounting, and strategic transactions make him a trusted expert in valuing life sciences assets and structuring complex deals. He is an alum of Babson College and Sciences Po, with advanced degrees in Business and Finance.
"A practical, straight-to-the-point guide for biotech leaders. It covers everything from valuation to partnerships—knowledge you don’t learn in a lab."
Adrien Châtillon, CEO and Serial Entrepreneur in Neuroscience
"Congratulations on this book — a rare and insightful work that demystifies business development / mergers & acquisitions in biopharma."
Loïc Gonnet, Global Head of Mergers & Acquisitions at Sanofi
"A well-rounded and insightful book that covers key aspects of the biopharma industry. A great resource for both experienced professionals and those just starting out."
Naji Gehchan, MD, MBA, Chief Medical & Development Officer I, Former Head of Global Development at Eli Lilly
